Jackson Creek Investment Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,149
Closed -$1.1M 345
2024
Q1
$1.1M Buy
+15,149
New +$1.01M 0.39% 107
2023
Q1
Sell
-15,161
Closed -$949K 353
2022
Q4
$949K Sell
15,161
-5,292
-26% -$303K 0.42% 66
2022
Q3
$1.02M Sell
20,453
-1,347
-6% -$74.6K 0.48% 34
2022
Q2
$1.31M Sell
21,800
-1,784
-8% -$98.4K 0.53% 11
2022
Q1
$1.25M Buy
23,584
+1,404
+6% +$81.1K 0.46% 44
2021
Q4
$1.34M Sell
22,180
-1,550
-7% -$92K 0.48% 35
2021
Q3
$1.33M Buy
23,730
+208
+0.9% +$11.4K 0.49% 32
2021
Q2
$1.23M Sell
23,522
-2,742
-10% -$132K 0.46% 53
2021
Q1
$1.16M Buy
+26,264
New +$1.1M 0.4% 100
2020
Q4
Sell
-16,535
Closed -$602K 338
2020
Q3
$602K Buy
+16,535
New +$615K 0.27% 205

Other funds holding PBH

Jackson Creek Investment Advisors's PBH Position: Q2 2024 in Review

Jackson Creek Investment Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 15,149 shares — an estimated $1.1M sold.

Jackson Creek Investment Advisors first reported a position in PBH in Q3 2020 and held it in 10 quarters. The position peaked at $1.34M in Q4 2021. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.

  • Jackson Creek Investment Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 15,149 Prestige Consumer Healthcare shares in Q2 2024, an estimated $1.1M.
  • Jackson Creek Investment Advisors first reported a position in Prestige Consumer Healthcare in Q3 2020 and held it in 10 quarters.
  • Jackson Creek Investment Advisors's Prestige Consumer Healthcare position peaked at $1.34M in Q4 2021.
  • 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.